5 Key Takeaways
-
1
Corneal crosslinking technology has transformed keratoconus treatment, reducing the need for full-thickness corneal transplants.
-
2
Early detection and intervention are crucial in managing keratoconus, allowing for proactive treatment and better patient outcomes.
-
3
The recent approval of epi-on crosslinking enhances patient comfort and may enable simultaneous treatment of both eyes.
-
4
Collaboration between optometrists and ophthalmologists is essential for identifying candidates for crosslinking earlier.
-
5
Currently, only 15% to 20% of eligible keratoconus patients receive crosslinking treatment, indicating a need for improved outreach.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.